Cargando…
Tratamientos farmacológicos de los pacientes con COVID19: interacciones e indicaciones
The search for effective treatments against COVID-19 in the current pandemic has presented the scientific community with an enormous challenge. In fact, there is still no effective treatment for SARS-CoV-2 infection, apart from supportive measures. Research has focused on re-examining antiviral drug...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Cardiología. Published by Elsevier España, S.L.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668175/ http://dx.doi.org/10.1016/S1131-3587(20)30033-9 |
_version_ | 1783610441677668352 |
---|---|
author | Iglesias, Mercedes Benavent, Eva Murillo, Óscar Luis Ferreiro, José |
author_facet | Iglesias, Mercedes Benavent, Eva Murillo, Óscar Luis Ferreiro, José |
author_sort | Iglesias, Mercedes |
collection | PubMed |
description | The search for effective treatments against COVID-19 in the current pandemic has presented the scientific community with an enormous challenge. In fact, there is still no effective treatment for SARS-CoV-2 infection, apart from supportive measures. Research has focused on re-examining antiviral drugs that were previously used against other viral infections and on the use of anti-inflammatories, since COVID-19 patients can develop a hyperinflammatory state, which is associated with a poorer disease prognosis. However, these drugs, sometimes administered on a compassionate-use basis, can cause serious side effects or drug interactions that we should be aware of. The aim of this article is to provide an overview of what is currently known about the pharmacological therapies most frequently used against COVID-19 in our field, while paying particular attention to the adverse events and drug interactions that can affect the cardiovascular system. |
format | Online Article Text |
id | pubmed-7668175 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Sociedad Española de Cardiología. Published by Elsevier España, S.L. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76681752020-11-16 Tratamientos farmacológicos de los pacientes con COVID19: interacciones e indicaciones Iglesias, Mercedes Benavent, Eva Murillo, Óscar Luis Ferreiro, José Revista Española de Cardiología Suplementos Article The search for effective treatments against COVID-19 in the current pandemic has presented the scientific community with an enormous challenge. In fact, there is still no effective treatment for SARS-CoV-2 infection, apart from supportive measures. Research has focused on re-examining antiviral drugs that were previously used against other viral infections and on the use of anti-inflammatories, since COVID-19 patients can develop a hyperinflammatory state, which is associated with a poorer disease prognosis. However, these drugs, sometimes administered on a compassionate-use basis, can cause serious side effects or drug interactions that we should be aware of. The aim of this article is to provide an overview of what is currently known about the pharmacological therapies most frequently used against COVID-19 in our field, while paying particular attention to the adverse events and drug interactions that can affect the cardiovascular system. Sociedad Española de Cardiología. Published by Elsevier España, S.L. 2020 2020-11-16 /pmc/articles/PMC7668175/ http://dx.doi.org/10.1016/S1131-3587(20)30033-9 Text en Copyright © 2020 Sociedad Española de Cardiología. Published by Elsevier España, S.L. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Iglesias, Mercedes Benavent, Eva Murillo, Óscar Luis Ferreiro, José Tratamientos farmacológicos de los pacientes con COVID19: interacciones e indicaciones |
title | Tratamientos farmacológicos de los pacientes con COVID19: interacciones e indicaciones |
title_full | Tratamientos farmacológicos de los pacientes con COVID19: interacciones e indicaciones |
title_fullStr | Tratamientos farmacológicos de los pacientes con COVID19: interacciones e indicaciones |
title_full_unstemmed | Tratamientos farmacológicos de los pacientes con COVID19: interacciones e indicaciones |
title_short | Tratamientos farmacológicos de los pacientes con COVID19: interacciones e indicaciones |
title_sort | tratamientos farmacológicos de los pacientes con covid19: interacciones e indicaciones |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668175/ http://dx.doi.org/10.1016/S1131-3587(20)30033-9 |
work_keys_str_mv | AT iglesiasmercedes tratamientosfarmacologicosdelospacientesconcovid19interaccioneseindicaciones AT benaventeva tratamientosfarmacologicosdelospacientesconcovid19interaccioneseindicaciones AT murillooscar tratamientosfarmacologicosdelospacientesconcovid19interaccioneseindicaciones AT luisferreirojose tratamientosfarmacologicosdelospacientesconcovid19interaccioneseindicaciones |